510(k) Report

FDA applicant

Anticancer, Inc.

San Diego, CA3 decisions2003–20120 recalls

FDA records 3 decisions for Anticancer, Inc. (San Diego, CA) from 2003 to 2012: 3 510(k) clearances. Most are in product codes LPS (Urinary Homocystine (Nonquantitative) Test…) and CDD (Radioassay, Vitamin B12). Its devices cite 3 predicates, 1 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Anticancer, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2012

2008: 12012: 1
2007high 1 (2008) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Anticancer, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Anticancer, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • LPSUrinary Homocystine (Nonquantitative) Test System2decisions
  • CDDRadioassay, Vitamin B121decision

Whose devices does it build on?

Its devices cite 3 predicates; 1 are its own earlier devices. The firms it cites most:

Which of its devices are cited most?

Its devices that later submissions most often claim equivalence to.

  • K030754A/C Enzymatic Homocysteine AssayAnticancer, Inc. · 20031cites it

What has FDA decided for it lately?

  • K111260A/C Enzymatic Vitamin B6 AssayAnticancer, Inc. · 2012
  • K080851A/C Portable Enzymatic Homocysteine AssayAnticancer, Inc. · 2008
  • K030754A/C Enzymatic Homocysteine AssayAnticancer, Inc. · 2003

All 3 as Anticancer, Inc. →